Zusammenfassung
Eine Vielzahl von Karzinomen wird durch eine chronische Inflammation hervorgerufen. Auch beim Prostatakarzinom scheint die chronische Entzündung/Inflammation eine wichtige Bedeutung in der Karzinogenese zu spielen. Ziel dieser Arbeit ist es, die epidemiologischen, morphologischen, molekularbiologischen und klinischen Aspekte der Prostatitis und des Prostatakarzinoms zu beleuchten.
Abstract
Chronic inflammation seems of importance in multiple types of cancer. Numerous reports have revealed a potential link between chronic prostatatic inflammation and prostate cancer. The aim of this paper is to review the epidemiological, moprphological, molecular and clinical aspects of prostattic inflammation and prostate cancer.
This is a preview of subscription content, log in via an institution to check access.
Literatur
De Marzo AM, Platz EA, Sutcliffe S et al (2007) Inflammation in prostate carcinogenesis. Nat Rev Cancer 7:256–269
Wagenlehner FM, Elkahwaji JE, Algaba F et al (2007) The role of inflammation and infection in the pathogenesis of prostate carcinoma. BJU Int 100:733–737
Nickel JC, Downey J, Hunter D, Clark J (2001) Prevalence of prostatitis-like symptoms in a population based study using the National Institutes of Health chronic prostatitis symptom index. J Urol 165:842–845
Daniels NA, Ewing SK, Zmuda JM et al (2005) Correlates and prevalence of prostatitis in a large community-based cohort of older men. Urology 66:964–970
Dennis LK, Lynch CF, Torner JC (2002) Epidemiologic association between prostatitis and prostate cancer. Urology 60:78–83
Bastian PJ, Carter BH, Bjartell A et al (2009) Insignificant prostate cancer and active surveillance: from definition to clinical implications. Eur Urol 55:1321–1330
De Marzo AM, Marchi VL, Epstein JI, Nelson WG (1999) Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol 155:1985–1992
Shah R, Mucci NR, Amin A et al (2001) Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol 158:1767–1773
Bastian PJ, Yegnasubramanian S, Palapattu GS et al (2004) Molecular biomarker in prostate cancer: the role of CpG island hypermethylation. Eur Urol 46:698–708
Nelson WG, De Marzo AM, Isaacs WB (2003) Prostate cancer. N Engl J Med 349:366–381
Nakayama M, Bennett CJ, Hicks JL et al (2003) Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol 163:923–933
Bardia A, Platz EA, Yegnasubramanian S et al (2009) Anti-inflammatory drugs, antioxidants and prostate cancer prevention. Curr Opin Pharmacol 9:419–426
Ames BN, Gold LS, Willett WC (1995) The causes and prevention of cancer. Proc Natl Acad Sci USA 92:5258–5265
Interessenkonflikt
Der korrespondierende Autor gibt an, dass kein Interessenkonflikt besteht.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bastian, P., Nuhn, P., Stadler, T. et al. Prostatitis und Prostatakarzinom. Urologe 49, 636–638 (2010). https://doi.org/10.1007/s00120-010-2254-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00120-010-2254-3